AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 281: G865-G869, 2001;
0193-1857/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (45)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarke, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, S. D.
Vol. 281, Issue 4, G865-G869, October 2001

THEME
Nonalcoholic Steatosis and Steatohepatitis.
I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription

Steven D. Clarke

Graduate Program of Nutrition and Institute of Cell and Molecular Biology, University of Texas at Austin, Austin, Texas 78712

This review addresses the hypothesis that polyunsaturated fatty acids (PUFA), particularly those of the n-3 family, play pivotal roles as "fuel partitioners" in that they direct fatty acids away from triglyceride storage and toward oxidation and they enhance glucose flux to glycogen. In doing this, PUFA may reduce the risk of enhanced cellular apoptosis associated with excessive cellular lipid accumulation. PUFA exert their beneficial effects by upregulating the expression of genes encoding proteins involved in fatty acid oxidation while simultaneously downregulating genes encoding proteins of lipid synthesis. PUFA govern oxidative gene expression by activating the transcription factor peroxisome proliferator-activated receptor-alpha . PUFA suppress lipogenic gene expression by reducing the nuclear abundance and DNA binding affinity of transcription factors responsible for imparting insulin and carbohydrate control to lipogenic and glycolytic genes. In particular, PUFA suppress the nuclear abundance and expression of sterol regulatory element binding protein-1 and reduce the DNA binding activities of nuclear factor Y, stimulatory protein 1, and possibly hepatic nuclear factor-4. Collectively, the studies discussed suggest that the fuel "repartitioning" and gene expression actions of PUFA should be considered among the criteria used in defining the dietary needs of n-6 and n-3 fatty acids and in establishing the dietary ratio of n-6 to n-3 fatty acids needed for optimum health benefit.

sterol regulatory element binding protein; fatty livers; nuclear factor Y; transcription


This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
A. Orgaard and L. Jensen
The Effects of Soy Isoflavones on Obesity
Experimental Biology and Medicine, September 1, 2008; 233(9): 1066 - 1080.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Svegliati-Baroni, C. Candelaresi, S. Saccomanno, G. Ferretti, T. Bachetti, M. Marzioni, S. De Minicis, L. Nobili, R. Salzano, A. Omenetti, et al.
A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats: Role of Peroxisome Proliferator-Activated Receptor-{alpha} and n-3 Polyunsaturated Fatty Acid Treatment on Liver Injury
Am. J. Pathol., September 1, 2006; 169(3): 846 - 860.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
H. t. Dieck, F. Doring, D. Fuchs, H.-P. Roth, and H. Daniel
Transcriptome and Proteome Analysis Identifies the Pathways That Increase Hepatic Lipid Accumulation in Zinc-Deficient Rats
J. Nutr., February 1, 2005; 135(2): 199 - 205.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Medina, L. I. Fernandez-Salazar, L. Garcia-Buey, and R. Moreno-Otero
Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis
Diabetes Care, August 1, 2004; 27(8): 2057 - 2066.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
J. L. Griffin, S. A. Bonney, C. Mann, A. M. Hebbachi, G. F. Gibbons, J. K. Nicholson, C. C. Shoulders, and J. Scott
An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver
Physiol Genomics, April 13, 2004; 17(2): 140 - 149.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
E.-J. Freyse, T. Giessmann, K. J. Petzke, S. Knospe, G. Engel, P. Heinke, C. C. Metges, and W. Siegmund
Effects of fatty acids on hepatic amino acid catabolism and fibrinogen synthesis in young healthy volunteers
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E54 - E62.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. Tang, H. P. Cho, M. T. Nakamura, and S. D. Clarke
Regulation of human {Delta}-6 desaturase gene transcription: identification of a functional direct repeat-1 element
J. Lipid Res., April 1, 2003; 44(4): 686 - 695.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
A. Vecchini, V. Ceccarelli, P. Orvietani, P. Caligiana, F. Susta, L. Binaglia, G. Nocentini, C. Riccardi, and P. Di Nardo
Enhanced expression of hepatic lipogenic enzymes in an animal model of sedentariness
J. Lipid Res., April 1, 2003; 44(4): 696 - 704.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Rajas, A. Gautier, I. Bady, S. Montano, and G. Mithieux
Polyunsaturated Fatty Acyl Coenzyme A Suppress the Glucose-6-phosphatase Promoter Activity by Modulating the DNA Binding of Hepatocyte Nuclear Factor 4alpha
J. Biol. Chem., May 3, 2002; 277(18): 15736 - 15744.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online